Clinical Trials List
Protocol NumberML43431
Active
2022-02-01 - 2028-01-31
Phase I/II
Recruiting1
ICD-10C15.3
Malignant neoplasm of upper third of esophagus
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9150.0
Malignant neoplasm of cervical esophagus
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Chia-Chi Lin Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- FENG-MING HSU Division of Hematology & Oncology
- 黃培銘 Division of General Surgery
- JANG-MING LEE Division of General Surgery
- 郭弘揚 無
- Chih-Hung Hsu Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
32 participants
-
Global
0 participants
